{
    "clinical_study": {
        "@rank": "55268", 
        "arm_group": [
            {
                "arm_group_label": "Extended release naltrexone", 
                "arm_group_type": "Experimental", 
                "description": "One dose of intramuscular injection of 380mg extended-release naltrexone."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "One dose of intramuscular injection of placebo."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this protocol is to learn more about impulsive decision making in people who\n      use methamphetamines. The investigators would like to know if a medication called naltrexone\n      changes how people make decisions. The investigators would also like to know whether changes\n      in decision making can be observed by MRI (magnetic resonance imaging).\n\n      The research is conducted in Portland, OR."
        }, 
        "brief_title": "Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Methamphetamine Abuse", 
            "HIV"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Summary Inclusion Criteria:\n\n          -  Diagnostic and Statistical Manual (DSM)-IV Methamphetamine Dependence\n\n          -  Deemed healthy enough to participate by study physician\n\n          -  Age 18-55\n\n          -  Right handed\n\n          -  English-speaking\n\n        Summary Exclusion Criteria:\n\n          -  Current opioid use in the last 30 days; opioid abuse or dependence within past 5\n             years\n\n          -  Pregnancy\n\n          -  MRI contraindications (e.g. metal in head).\n\n        The research is conducted in Portland, OR."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01822132", 
            "org_study_id": "ALKIIT-KOR-034", 
            "secondary_id": "1R21DA033182-01A1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Extended release naltrexone", 
                "intervention_name": "Extended release naltrexone", 
                "intervention_type": "Drug", 
                "other_name": "Vivitrol"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Naltrexone", 
                "Methamphetamine", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health & Science University"
                }, 
                "investigator": {
                    "last_name": "Philip T Korthuis, MD, MPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Portland VA Medical Center"
                }, 
                "investigator": {
                    "last_name": "Willliam Hoffman, PhD, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade", 
        "overall_contact": {
            "email": "bielavit@ohsu.edu", 
            "last_name": "Sarann Bielavitz, BS", 
            "phone": "503-418-1944"
        }, 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "Philip T Korthuis, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Discounting Tasks", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01822132"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oregon Health and Science University", 
            "investigator_full_name": "P. Todd Korthuis", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Neural Mapping", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Methamphetamine use", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "HIV risk behaviors", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Antiretroviral adherence", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }
        ], 
        "source": "Oregon Health and Science University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}